Sclerosing cholangitis, race and sex

Area of Science:

• Gastroenterology
• Hepatology
• Immunogenetics

Background:

• Primary sclerosing cholangitis (PSC) affects 3-10% of ulcerative colitis (UC) patients, potentially increasing cancer risk.
• Ulcerative colitis is less prevalent in individuals of African descent compared to European populations.

Purpose of the Study:

• To investigate a cluster of ulcerative colitis cases with common features at a tertiary referral center.
• To assess the prevalence and risk of primary sclerosing cholangitis in patients with ulcerative colitis of diverse genetic backgrounds.

Main Methods:

• Retrospective review of medical records for all ulcerative colitis patients under regular follow-up.
• Analysis of patient demographics, focusing on genetic origin (African/Caribbean vs. European/Asian descent).
• Comparison of primary sclerosing cholangitis incidence between ethnic groups.

Main Results:

• Out of 166 UC patients, only four were of African or Caribbean origin (all women).
• Three of these four women developed primary sclerosing cholangitis within three years of UC diagnosis.
• This contrasts with four of 162 European/Asian descent patients developing PSC (Odds Ratio 119, p=0.0002).

Conclusions:

• Africans and Afro-Caribbeans, especially women, exhibit a markedly increased risk for primary sclerosing cholangitis in the context of ulcerative colitis.
• The observed association is not explained by common HLA DR or DQ types, suggesting other genetic influences.
• Findings point towards potential genetic predispositions influencing both enteric and hepatobiliary inflammatory conditions in specific ethnic groups.